tm
Seeing Is Believing
tm
Seeing Is Believing
PEAR is currently covered by 4 analysts with an average price target of $2.33. This is a potential upside of $2.33 (0%) from yesterday's end of day stock price of $0.
Pear Therapeutics's activity chart (see below) currently has 11 price targets and 16 ratings on display. The stock rating distribution of PEAR is 100% BUY.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 20-Mar-2023.
Currently out of the existing stock ratings of PEAR, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
1 years 8 months 9 days ago
(20-Mar-2023)
0/4 (0%)
$5.51 (221.29%)
Buy
$1
$0.99 (9900.00%)
$7
1 years 8 months 9 days ago
(20-Mar-2023)
0/3 (0%)
$0.79 (376.19%)
Buy
$5
1 years 8 months 12 days ago
(17-Mar-2023)
0/2 (0%)
$3 (150.00%)
What is PEAR (Pear Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PEAR (Pear Therapeutics) with a proven track record?
Which analyst has the current lower performing score on PEAR (Pear Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PEAR (Pear Therapeutics)?
Which analyst is the currently most bullish on PEAR (Pear Therapeutics)?
Which analyst is the currently most reserved on PEAR (Pear Therapeutics)?
